In Other News

• Blood-Based “Ageing Clock” Helps Predict Dementia Risk and Earlier Onset

• FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing

• Gene Signature Shows Promise for Depression Biomarker Testing

• Blood Test Refines Biopsy Decisions in Prostate Cancer

• AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development

• Researchers Map Protein and Glycosylation Across 15 Human Body Fluids

• CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics

• Digital Aging Twin Quantifies Biological Aging Across Multiple Organ Systems

• Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients

• Advanced Endoscopy Platform Recognized for Third Space Procedures

• Blood Gene Signature Differentiates Major Depressive Disorder

• AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development

• Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

• Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

• At-Home Blood and Cognitive Tests Support Dementia Risk Stratification

• Patented Isothermal Amplification Chemistry Advances Decentralized Testing

• Biomarkers and Molecular Testing Advance Precision Allergy Care

• Finger-Prick Blood Test Aids Early Tuberculosis Detection and Risk Stratification

• Urine Test Beats MRI in Identifying Prostate Cancer Upgrading During Active Surveillance

• Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing

• Direct-to-Patient Genetic Testing Identifies Hereditary Cancer Risk in Survivors

• Telomere Length Abnormalities Linked to Lymphoma Development

• Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia